Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis
      • Cardiovascular Disease
      • Severe Hypertriglyceridemia

    • Coronavirus disease (COVID-19) Resources

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Resources
      • All COVID-19 Updates
      • Vaccine Efforts
      • Antiviral Efforts
      • Partnerships & Anti-Infective Efforts
      • Supporting the Fight Against COVID-19
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Fight Fear with Facts: Three Tips That May Help You Continue Your Lung Cancer Treatment During the COVID-19 Pandemic

Fight Fear with Facts: Three Tips That May Help You Continue Your Lung Cancer Treatment During the COVID-19 Pandemic
YOUR HEALTH/ Fight Fear with Facts: Three Tips That May Help You Continue Your Lung Cancer Treatment During the COVID-19 Pandemic
July 10, 2020

Fight fear with facts and learn more about ways that may help you safely continue your treatment plans and attend regularly scheduled doctors’ visits. We’ve addressed some of the biggest stressors facing lung cancer patients during this unprecedented time.

Working with Your Doctor to Continue Treatment

A lot is uncertain right now, but your treatment plan does not have to be. While it can be scary to leave the safety of your home, it is crucial that decisions regarding your treatment plan are made jointly with your healthcare team. By having informed conversations with your healthcare providers about your treatment plan and how you are feeling on treatment, together you can properly assess the benefits and risks of starting, maintaining, adapting or pausing your current plan. Additionally, it is important to receive assurance from your doctor that you’ll be equipped with an adequate supply of your cancer medication during this time.

Leveraging telehealth services:
If you would like to have these conversations with your doctor but are hesitant about in-person visits, check with your doctor if telehealth or remote consultation services are available. Work with your doctor to determine the appropriate cadence of telehealth appointments so that your current treatment plan is not compromised. In order to use your time effectively, keep a journal throughout the week to remind you of any questions that have come up since your last appointment. Visit LUNGevity’s Role of Telehealth in the Era of COVID-19 for more FAQ’s regarding telehealth services.1

Top Questions to Ask your Doctor:

  • Do we need to change anything with my current treatment plan?
  • Will I be able to get my medicine as I usually do?
  • Is it safe for me to come in for scans or other procedures I normally undergo for my lung cancer?
  • If I can’t come into the hospital how do I keep connected with you?

Managing Scanxiety

Undergoing frequent tests and scans is a reality for people with lung cancer. At every stage of lung cancer treatment, a healthcare team relies on these tests to help determine the best care plan. As scans and results loom, patients can experience fear, uncertainty, and anxiety, commonly referred to as “scanxiety”.

Now coupled with the uncertainty of COVID-19 and the potential for delays in scans and results, people may find their scanxiety has heightened. While scanxiety is a common feeling in the lung cancer community, everyone copes with it differently. It’s important to find the best way for you to avoid the anxiety from overwhelming or consuming you. For tips on managing your scanxiety, visit LungCancerProfiles.com.

Resources & Support

Guidelines to help stay informed
Our biggest ally during this pandemic is knowledge. Staying informed helps you understand the virus and how it impacts you. To help you stay informed, the European Society for Medical Oncology (ESMO), is applying a tiered approach to guidance on the management of patients with cancer during the COVID-19 pandemic.

This approach considers the patient’s condition, the urgency of the planned cancer treatment, and its anticipated benefit in light of the potential risk of COVID-19 associated with the logistics of receiving treatment, as well as the available resources to safely provide treatment. For more information visit ASCO and ESMO for their respective guidelines.1

Support for patients taking Pfizer medicines
Knowing the ways to save on your medicine can be especially important now. For patients in the U.S., Pfizer Oncology Together™ can help you understand your insurance and identify what financial support may be available for your prescription. In addition, Pfizer Oncology Together can help you find a specialty pharmacy that can fill your prescription. Learn more about the Pfizer Oncology Together program here.2

Emotional Support
Besides your physical health, COVID-19 can impact your mental health and should not be overlooked. To ensure you’re getting the emotional support you need, Pfizer’s This is Living with Cancer website and app provides free helpful tools and resources designed to give you the type of support you need so that you can make the most out of each day.

For additional information1:

  • https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic
  • https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19
  • https://www.accc-cancer.org/home/attend/event-template/2020/04/03/default-calendar/clinical-trials-amid-covid-19
  • https://www.roycastle.org/covid-19/information-for-patients/treatment-advice/
  • https://go2foundation.org/resources-and-support/lung-cancer-and-coronavirus/
  • https://lungevity.org/for-patients-caregivers/covid-19-and-lung-cancer/weekly-updates-on-coronavirus-covid-19-from-lung

 

1 Pfizer is not affiliated with these organizations and is not responsible for the content posted to their websites. The information provided at these links is for educational purposes only and is not intended to replace discussions with a healthcare provider.
2 Pfizer Oncology Together™ is available for patients in the United States who are prescribed a Pfizer medicine for their disease.

MORE ON COVID-19
How to stay safe and prevent the spread.

The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheet at www.cvdvaccine.com.

Our biggest ally during this pandemic is knowledge. Staying informed helps you understand the virus and how it impacts you.

Related Hot Topics
Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
Some older people living with cancer aim for remission but lack needed resources to help make treatment decisions, global survey reveals
Some older people living with cancer aim for remission but lack needed…
Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
KZOO-Vials-in-Tray-2-(1)_380X220.jpg
Distributing Our COVID-19 Vaccine to the World
Scientists_Image_380X220.jpg
Albert Bourla Discusses Our FDA Submission
Covid Vaccine Study - What's Next
Our COVID-19 Vaccine Study – What’s Next?
KZOO_Filling_Line_10_380X300.jpg
COVID-19 Vaccine U.S. Distribution Fact Sheet
Tags
COVID-19
lung cancer
Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.